Variants in NR6A1 cause a novel oculo-vertebral-renal (OVR) syndrome

Uma M Neelathi,Ehsan Ullah,Aman George,Mara I Maftei,Elangovan Elangovan,Daniel Sanchez-Mendoza,Chloe Adams,David McGaughey,Yuri V Sergeev,Ranya AI Rawi,Amelia Naik,Chelsea Bender,Irene H Maumenee,Michel Michaelides,Tun Giap Tan,Siying Lin,Rafael Villasmil,Delphine Blain,Robert B Hufnagel,Gavin Arno,Rodrigo M Young,Bin Guan,Brian P Brooks
DOI: https://doi.org/10.1101/2024.11.09.24316578
2024-11-11
Abstract:Colobomatous microphthalmia is a potentially blinding congenital ocular malformation that can present either in isolation or together with other syndromic features. Despite a strong genetic component to disease, many cases lack a molecular diagnosis. We describe a novel autosomal dominant oculo-vertebral-renal (OVR) syndrome in six independent families characterized by colobomatous microphthalmia, missing vertebrae and congenital kidney abnormalities. Genome sequencing identified six rare variants in the orphan nuclear receptor gene NR6A1 in these families. We performed in silico, cellular and zebrafish experiments to demonstrate the NR6A1 variants were pathogenic or likely pathogenic for OVR syndrome. Knockdown of either or both zebrafish paralogs of NR6A1 results in abnormal eye and somite development, which was rescued by wild-type but not variant NR6A1 mRNA. Illustrating the power of genomic ascertainment in medicine, our study establishes NR6A1 as a critical factor in eye and vertebral development and a pleiotropic gene responsible for OVR syndrome.
Genetic and Genomic Medicine
What problem does this paper attempt to address?